AACR 2023
We’re attending AACR 2023, held from April 14-19 in Orlando, Florida! For the latest advances, service offerings, and promotions, register now to visit our team at Booth 723, which will be open from April 16-19. Be sure to also visit our 25 posters, which can now be added to your AACR itinerary.
Off-the-Shelf Mouse Model Posters
Poster Number: 3233
Session: Combination Immunotherapies 1
Date/Time: April 17, 2023, 1:30 PM – 5:00 PM
Poster Number: 3286
Session: Combination Immunotherapies 2
Date/Time: April 17, 2023, 1:30 PM – 5:00 PM
Poster Number: 5208
Session: Novel Preclinical Models for Cancer Immunotherapy
Date/Time: April 18, 2023, 1:30 PM – 5:00 PM
Poster Number: 5207
Session: Novel Preclinical Models for Cancer Immunotherapy
Date/Time: April 18, 2023, 1:30 PM – 5:00 PM
Poster Number: 5209
Session: Novel Preclinical Models for Cancer Immunotherapy
Date/Time: April 18, 2023, 1:30 PM – 5:00 PM
Humanized OX40/OX40L Mice as a Tool for Evaluating Novel Therapeutics
Poster Number: 5178
Session: Modifiers of the Tumor Microenvironment
Date/Time: April 18, 2023, 1:30 PM – 5:00 PM
In vivo Efficacy Evaluation of Anti-Human VEGFR2 Antibodies in Humanized B-hVEGFR2 Mice
Poster Number: 4592
Session: Advances in Angiogenesis
Date/Time: April 18, 2023, 1:30 PM – 5:00 PM
In vivo Efficacy of an Anti-Human IL11RA Antibody in B-hIL11RA Mice With APAP-Induced Liver Damage
Poster Number: 3993
Session: Oncogenes and Tumor Suppressor Genes as Targets for Therapy 3
Date/Time: April 18, 2023, 9:00 AM – 12:30 PM
Novel Humanized CD36 Mouse Model for Therapeutic Studies
Poster Number: 5196
Session: Novel Preclinical Models for Cancer Immunotherapy
Date/Time: April 18, 2023, 1:30 PM – 5:00 PM
RenMabTM-Based Fully Human Antibody Discovery Platforms
Discovery of RenNano®-Derived Human Heavy-Chain-Only Antibodies That Cross the Blood-Brain-Barrier
Poster Number: LB211
Session: Late-Breaking Research: Immunology 2
Date/Time: April 18, 2023, 9:00 AM – 12:30 PM
RenNano® Mice: A Heavy-Chain-Only Antibody Platform for the Generation of Nanobody Therapeutics
Poster Number: LB210
Session: Late-Breaking Research: Immunology 2
Date/Time: April 18, 2023, 9:00 AM – 12:30 PM
Poster Number: 2752
Session: Innovative Assay Technologies
Date/Time: April 17, 2023, 1:30 PM – 5:00 PM
Poster Number: 5320
Session: High-throughput Screening, Lead Identification and Optimization, and in Silico Drug Discovery
Date/Time: April 18, 2023, 1:30 PM – 5:00 PM
Fully Human Monoclonal Antibody Assets
Poster Number: 6436
Session: Immunotherapy Strategies and Mechanisms
Date/Time: April 19, 2023, 9:00 AM – 12:30 PM
Poster Number: 1528
Session: Antibody Drug Conjugates
Date/Time: April 17, 2023, 9:00 AM – 12:30 PM
Poster Number: 6435
Session: Immunotherapy Strategies and Mechanisms
Date/Time: April 19, 2023, 9:00 AM – 12:30 PM
Poster Number: 1866
Session: Therapeutic Antibodies 1
Date/Time: April 17, 2023, 9:00 AM – 12:30 PM
RenLite®-derived Fully Human Bispecific ADC Assets
Poster Number: 2977
Session: Therapeutic Antibodies 3
Date/Time: April 17, 2023, 1:30 PM – 5:00 PM
YH013, a Novel Bispecific EGFR x MET Antibody-Drug Conjugate, Exhibits Potent Anti-Tumor Efficacy
Poster Number: 2978
Session: Therapeutic Antibodies 3
Date/Time: April 17, 2023, 1:30 PM – 5:00 PM
Poster Number: 6325
Session: Anticancer Immunotherapeutics
Date/Time: April 19, 2023, 9:00 AM – 12:30 PM
BCG022: A Novel Bispecific Antibody-Drug Conjugate Targeting HER3 and MET
Poster Number: LB212
Session: Late-Breaking Research: Immunology 2
Date/Time: April 18, 2023, 9:00 AM – 12:30 PM
Poster Number: LB216
Session: Late-Breaking Research: Immunology 2
Date/Time: April 18, 2023, 9:00 AM – 12:30 PM
Poster Number: LB215
Session: Late-Breaking Research: Immunology 2
Date/Time: April 18, 2023, 9:00 AM – 12:30 PM
Poster Number: LB214
Session: Late-Breaking Research: Immunology 2
Date/Time: April 18, 2023, 9:00 AM – 12:30 PM
Identification of DM004, A First-In-Class Anti-5T4/MET Bispecific Antibody-Drug Conjugate
Poster Number: LB213
Session: Late-Breaking Research: Immunology 2
Date/Time: April 18, 2023, 9:00 AM – 12:30 PM
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world. (Source: AACR)
